Brivaracetam Tablet, Film Coated
Product Images NDC 70710-1588

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 70710-1588). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 01)

Chemical structure of brivaracetam, depicted as a molecular diagram showing its key atoms and bonds, including a pyrrolidinone ring attached to an amide group and alkyl side chains.*

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 02)

A bar chart comparing the proportion of patients (%) across different reductions in seizure frequency from baseline (%) among four groups: Placebo, Brivaracetam 50 mg/day, Brivaracetam 100 mg/day, and Brivaracetam 200 mg/day. The x-axis shows categorical ranges of seizure frequency reduction, and the y-axis shows the proportion of patients. The chart visually distinguishes responses among dosage groups and placebo.*

FDA Label Image

Brivaracetam Tablets (0c028f49 F370 40ee 92a0 2efad816effc 03)

Brivaracetam Tablets 10 mg film-coated oral tablets label from Zydus Pharmaceuticals USA Inc. The label indicates a package of 60 tablets with NDC 70710-1584-6. It includes dosing instructions, storage conditions, child-resistant packaging notice, and distributor information for Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 04)

Label for Brivaracetam Tablets 25 mg, film-coated oral tablets. The label shows the product name, strength, and quantity of 60 tablets. It includes the NDC 70710-1585-6 and indicates the labeler as Zydus Pharmaceuticals USA Inc. The label also contains instructions for pharmacists, storage conditions, child-resistance information, and distributor details for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.*

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 05)

Brivaracetam Tablets 50 mg film-coated oral tablets in a 60-tablet package. The label includes the NDC number 70710-1586-6 and indicates that the package is child-resistant. It features the Zydus logo and specifies dispensing instructions for pharmacists. Manufactured by Zydus Lifesciences Ltd. in India and distributed by Zydus Pharmaceuticals (USA) Inc., New Jersey.*

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 06)

Brivaracetam Tablets 75 mg film-coated oral tablets by Zydus Pharmaceuticals USA Inc. The label states a package size of 60 tablets and includes storage instructions, child-resistance information, and mentions the medication guide availability. The label also includes the NDC number 70710-1587-6 and a barcode.*

FDA Label Image

Image (0c028f49 F370 40ee 92a0 2efad816effc 07)

Label for Brivaracetam Tablets 100 mg oral film-coated tablets by Zydus Pharmaceuticals USA Inc. The package contains 60 tablets with NDC 70710-1588-6. The label includes dosage and storage instructions, child-resistant package warning, and distribution information for Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.